Abstract:Prognosis and appropriate treatment goals for older adults with diabetes vary greatly according to frailty. It is now recognised that changes may be needed to diabetes management in some older people. Whilst there is clear guidance on the evaluation of frailty and subsequent target setting for people living with frailty, there remains a lack of formal guidance for healthcare professionals in how to achieve these targets. The management of older adults with type 2 diabetes is complicated by comorbidities, shortened life expectancy and exaggerated consequences of adverse effects from treatment. In particular, older adults are more prone to hypoglycaemia and are more vulnerable to its consequences, including falls, fractures, hospitalisation, cardiovascular events and all-cause mortality. Thus, assessment of frailty should be a routine component of a diabetes review for all older adults, and glycaemic targets and therapeutic choices should be modified accordingly. Evidence suggests that over-treatment of older adults with type 2 diabetes is common, with many having had their regimens intensified over preceding years when they were in better health, or during more recent acute hospital admissions when their blood glucose levels might have been atypically high, and nutritional intake may vary. In addition, assistance in taking medications, as often occurs in later life following implementation of community care strategies or admittance to a care home, may dramatically improve treatment adherence, leading to a fall in glycated haemoglobin (HbA1c) levels. As a person with diabetes gets older, simplification, switching or de-escalation of the therapeutic regimen may be necessary, depending on their level of frailty and HbA1c levels. Consideration should be given, in particular, to de-escalation of therapies that may induce hypoglycaemia, such as sulphonylureas and shorter-acting insulins. We discuss the use of available glucose-lowering therapies in older adults and recommend simple glycaemic management algorithms according to their level of frailty.

Prise en charge du diabete de type 2 chez les patients fragiles

Management of type 2 diabetes in patients with frailty

Les particularités de prise en charge du sujet âgé en diabétologie

Chapter 11: The approach to achieving glycaemic control

Treating diabetes mellitus in older and oldest old patients

Diabetes and Frailty: An Expert Consensus Statement on the Management of Older Adults with Type 2 Diabetes

The role of Recent Pharmacotherapeutic Options on the Management of Treatment Resistant Type 2 Diabetes

[Aging well with diabetes]

Perte de l'autonomie et équilibre glycémique chez le sujet âgé diabétique

Treatment of type 2 diabetes mellitus in the elderly – Special considerations

Newer Glucose-Lowering Therapies in Older Adults with Type 2 Diabetes

Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care

Individualized glycaemic targets and pharmacotherapy in type 2 diabetes.

Challenges and opportunities in the management of type 2 diabetes in patients with lower extremity peripheral artery disease: a tailored diagnosis and treatment review

A Critical View over the Newest Antidiabetic Molecules in Light of Efficacy-A Systematic Review and Meta-Analysis

SGLT2 Inhibitors in the Prevention and Treatment of Cardiovascular Disease

Novel Therapeutics for Type 2 Diabetes Mellitus—A Look at the Past Decade and a Glimpse into the Future

Advances in Research on Type 2 Diabetes Mellitus Targets and Therapeutic Agents

Careful use to minimize adverse events of oral antidiabetic medications in the elderly

Les facteurs prédictifs d'hypoglycémie sévère chez un diabétique type 1

Diabetic kidney disease: update on clinical management and non-glycaemic effects of newer medications for type 2 diabetes